US Stock MarketDetailed Quotes

LPHM LEE PHARMACEUTICALS

Watchlist
  • 0.099000
  • 0.0000000.00%
15min DelayClose Jul 28 16:00 ET
409.38KMarket Cap-1178P/E (TTM)

LEE PHARMACEUTICALS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2005
(Q2)Mar 31, 2005
(Q1)Dec 31, 2004
(FY)Sep 30, 2004
(Q4)Sep 30, 2004
(Q3)Jun 30, 2004
(Q2)Mar 31, 2004
(Q1)Dec 31, 2003
(FY)Sep 30, 2003
(Q4)Sep 30, 2003
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
172.16%210K
18.87%441K
-11.87%-603K
-1,546.77%-897K
11.87%-438K
-162.72%-291K
302.73%371K
-293.88%-539K
151.24%62K
-1.43%-497K
Net income from continuing operations
100.23%1K
78.24%-104K
608.33%85K
-11.32%-1.23M
60.07%-331K
-95.48%-432K
-582.86%-478K
-25.00%12K
-21.19%-1.1M
-11.13%-829K
Operating gains losses
-151.72%-45K
77.36%-48K
-1,048.57%-804K
-14.21%-209K
80.00%-14K
328.95%87K
-3,128.57%-212K
14.63%-70K
-127.81%-183K
-109.45%-70K
Depreciation and amortization
1,400.00%165K
-53.48%107K
108.91%211K
11.32%413K
-28.28%71K
-88.78%11K
164.37%230K
16.09%101K
-7.48%371K
216.47%99K
Change In working capital
106.98%89K
-41.52%486K
83.68%-95K
-86.91%128K
-154.13%-164K
-93.12%43K
501.45%831K
-326.46%-582K
463.57%978K
175.75%303K
-Change in receivables
-43.04%262K
-71.37%134K
92.81%-43K
-185.38%-432K
-289.55%-762K
2,200.00%460K
403.90%468K
-351.26%-598K
250.15%506K
196.40%402K
-Change in inventory
43.05%-168K
-913.33%-152K
138.30%336K
471.59%327K
663.08%496K
-455.42%-295K
89.93%-15K
262.07%141K
-877.78%-88K
-79.81%65K
-Change in payables and accrued expense
-58.41%-358K
28.94%303K
-229.24%-358K
349.38%601K
142.86%315K
-279.37%-226K
-8.20%235K
147.32%277K
-173.03%-241K
-3,400.00%-735K
-Change in other current assets
203.61%252K
58.42%160K
37.89%-141K
-241.58%-286K
-267.59%-243K
-70.04%83K
152.60%101K
-710.71%-227K
210.99%202K
186.31%145K
-Change in other current liabilities
380.95%101K
-2.38%41K
163.43%111K
-113.69%-82K
-92.96%30K
-82.35%21K
31.25%42K
-895.45%-175K
943.66%599K
467.24%426K
Cash from discontinued investing activities
Operating cash flow
172.16%210K
18.87%441K
-11.87%-603K
-1,546.77%-897K
11.87%-438K
-162.72%-291K
302.73%371K
-293.88%-539K
151.24%62K
-1.43%-497K
Investing cash flow
Cash flow from continuing investing activities
-111.25%-169K
19.77%-69K
4,980.00%732K
-239.77%-369K
-125.00%-188K
71.63%-80K
-40.98%-86K
89.66%-15K
228.78%264K
159.31%752K
Net PPE purchase and sale
7.50%-74K
-852.33%-819K
4,980.00%732K
-204.24%-369K
-129.98%-188K
-19.40%-80K
5.49%-86K
86.96%-15K
-19.73%354K
127.17%627K
Net business purchase and sale
----
----
----
----
----
----
----
----
86.07%-90K
----
Net other investing changes
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-111.25%-169K
19.77%-69K
4,980.00%732K
-239.77%-369K
-125.00%-188K
71.63%-80K
-40.98%-86K
89.66%-15K
228.78%264K
159.31%752K
Financing cash flow
Cash flow from continuing financing activities
-130.13%-116K
12.76%-294K
-123.23%-138K
480.36%1.28M
338.20%636K
304.79%385K
-242.19%-337K
603.39%594K
-196.83%-336K
-227.14%-267K
Net issuance payments of debt
-130.13%-116K
12.76%-294K
-123.23%-138K
480.36%1.28M
338.20%636K
304.79%385K
-242.19%-337K
603.39%594K
-196.83%-336K
-227.14%-267K
Cash from discontinued financing activities
Financing cash flow
-130.13%-116K
12.76%-294K
-123.23%-138K
480.36%1.28M
338.20%636K
304.79%385K
-242.19%-337K
603.39%594K
-196.83%-336K
-227.14%-267K
Net cash flow
Beginning cash position
2,325.00%97K
-66.07%19K
75.00%28K
-38.46%16K
-35.71%18K
-88.24%4K
36.59%56K
-38.46%16K
420.00%26K
75.00%28K
Current changes in cash
-635.71%-75K
250.00%78K
-122.50%-9K
220.00%12K
183.33%10K
333.33%14K
-642.86%-52K
166.67%40K
-147.62%-10K
-220.00%-12K
End cash Position
22.22%22K
2,325.00%97K
-66.07%19K
75.00%28K
75.00%28K
-35.71%18K
-88.24%4K
36.59%56K
-38.46%16K
-38.46%16K
Free cash flow
136.66%136K
30.53%372K
-13.00%-626K
-410.04%-1.27M
-17.76%-630K
-193.45%-371K
204.01%285K
-439.88%-554K
-1.22%-249K
-4.09%-535K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2005(Q2)Mar 31, 2005(Q1)Dec 31, 2004(FY)Sep 30, 2004(Q4)Sep 30, 2004(Q3)Jun 30, 2004(Q2)Mar 31, 2004(Q1)Dec 31, 2003(FY)Sep 30, 2003(Q4)Sep 30, 2003
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 172.16%210K18.87%441K-11.87%-603K-1,546.77%-897K11.87%-438K-162.72%-291K302.73%371K-293.88%-539K151.24%62K-1.43%-497K
Net income from continuing operations 100.23%1K78.24%-104K608.33%85K-11.32%-1.23M60.07%-331K-95.48%-432K-582.86%-478K-25.00%12K-21.19%-1.1M-11.13%-829K
Operating gains losses -151.72%-45K77.36%-48K-1,048.57%-804K-14.21%-209K80.00%-14K328.95%87K-3,128.57%-212K14.63%-70K-127.81%-183K-109.45%-70K
Depreciation and amortization 1,400.00%165K-53.48%107K108.91%211K11.32%413K-28.28%71K-88.78%11K164.37%230K16.09%101K-7.48%371K216.47%99K
Change In working capital 106.98%89K-41.52%486K83.68%-95K-86.91%128K-154.13%-164K-93.12%43K501.45%831K-326.46%-582K463.57%978K175.75%303K
-Change in receivables -43.04%262K-71.37%134K92.81%-43K-185.38%-432K-289.55%-762K2,200.00%460K403.90%468K-351.26%-598K250.15%506K196.40%402K
-Change in inventory 43.05%-168K-913.33%-152K138.30%336K471.59%327K663.08%496K-455.42%-295K89.93%-15K262.07%141K-877.78%-88K-79.81%65K
-Change in payables and accrued expense -58.41%-358K28.94%303K-229.24%-358K349.38%601K142.86%315K-279.37%-226K-8.20%235K147.32%277K-173.03%-241K-3,400.00%-735K
-Change in other current assets 203.61%252K58.42%160K37.89%-141K-241.58%-286K-267.59%-243K-70.04%83K152.60%101K-710.71%-227K210.99%202K186.31%145K
-Change in other current liabilities 380.95%101K-2.38%41K163.43%111K-113.69%-82K-92.96%30K-82.35%21K31.25%42K-895.45%-175K943.66%599K467.24%426K
Cash from discontinued investing activities
Operating cash flow 172.16%210K18.87%441K-11.87%-603K-1,546.77%-897K11.87%-438K-162.72%-291K302.73%371K-293.88%-539K151.24%62K-1.43%-497K
Investing cash flow
Cash flow from continuing investing activities -111.25%-169K19.77%-69K4,980.00%732K-239.77%-369K-125.00%-188K71.63%-80K-40.98%-86K89.66%-15K228.78%264K159.31%752K
Net PPE purchase and sale 7.50%-74K-852.33%-819K4,980.00%732K-204.24%-369K-129.98%-188K-19.40%-80K5.49%-86K86.96%-15K-19.73%354K127.17%627K
Net business purchase and sale --------------------------------86.07%-90K----
Net other investing changes --0------------------------------------
Cash from discontinued investing activities
Investing cash flow -111.25%-169K19.77%-69K4,980.00%732K-239.77%-369K-125.00%-188K71.63%-80K-40.98%-86K89.66%-15K228.78%264K159.31%752K
Financing cash flow
Cash flow from continuing financing activities -130.13%-116K12.76%-294K-123.23%-138K480.36%1.28M338.20%636K304.79%385K-242.19%-337K603.39%594K-196.83%-336K-227.14%-267K
Net issuance payments of debt -130.13%-116K12.76%-294K-123.23%-138K480.36%1.28M338.20%636K304.79%385K-242.19%-337K603.39%594K-196.83%-336K-227.14%-267K
Cash from discontinued financing activities
Financing cash flow -130.13%-116K12.76%-294K-123.23%-138K480.36%1.28M338.20%636K304.79%385K-242.19%-337K603.39%594K-196.83%-336K-227.14%-267K
Net cash flow
Beginning cash position 2,325.00%97K-66.07%19K75.00%28K-38.46%16K-35.71%18K-88.24%4K36.59%56K-38.46%16K420.00%26K75.00%28K
Current changes in cash -635.71%-75K250.00%78K-122.50%-9K220.00%12K183.33%10K333.33%14K-642.86%-52K166.67%40K-147.62%-10K-220.00%-12K
End cash Position 22.22%22K2,325.00%97K-66.07%19K75.00%28K75.00%28K-35.71%18K-88.24%4K36.59%56K-38.46%16K-38.46%16K
Free cash flow 136.66%136K30.53%372K-13.00%-626K-410.04%-1.27M-17.76%-630K-193.45%-371K204.01%285K-439.88%-554K-1.22%-249K-4.09%-535K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg